Over 30 European universities, research institutes and companies are joining forces in a six-year, €85 million program to develop novel antibiotics against Gram-negative pathogens. [ + ]

Cognitive assessment and training company Cogstate has announced that its technology will be used in a large paediatric clinical trial in the United States. [ + ]

The winners of the 2014 BHP Billiton Science and Engineering Awards were announced last week in Melbourne by the Chief Executive Officer of BHP Billiton, Andrew Mackenzie, and CSIRO Chief Executive, Megan Clark. [ + ]

Antibody search engine CiteAb, founded by Dr Andrew Chalmers from the University of Bath in collaboration with web development company Storm Consultancy, has officially spun out from the university. [ + ]

The National Health and Medical Research Council (NHMRC) has released Measuring Up 2013 - a report which analyses and compares the publication output of NHMRC health and medical research funding with other Australian research. [ + ]

Fronde is holding an introductory webinar about business cloud computing in 2014 and what this can mean for businesses in the science space. The webinar will be held on Wednesday 19 February from 9-9.30 am AEDT. [ + ]

Alchemia (ASX:ACL) has selected a permanent successor to the post of chairman, following the retirement of long-serving chair Mel Bridges last year. [ + ]

AusBiotech has responded on behalf of its members to the federal government's review of employee share schemes (ESS) for start-ups, making both direct and written submissions to the review last week. [ + ]

Oxford Gene Technology (OGT), a provider of innovative genetics research and biomarker solutions to advance molecular medicine, has been awarded a tender by the UK National Health Service (NHS) for the supply of oligo-based arrays for cytogenetics. [ + ]

An easy-to-use HIV diagnostic has received funding of US$1.6 million to kickstart field studies. [ + ]

A simple method for capturing cancer cells in the blood could improve patient prognosis and response to treatment. [ + ]

Regulatory agencies from Latvia, Lithuania, Ukraine and Belarus have joined their Belgian counterpart in signing off on Prima BioMed's (ASX:PRR) CAN-004 trial. [ + ]

Viralytics (ASX:VLA) has been granted a notice of allowance for a US patent covering anticancer candidate Cavatak and the family of oncolytic viruses to which it belongs. [ + ]

An international collaboration of scientists has revealed that two of the world's most devastating plagues were caused by distinct versions of the same pathogen. [ + ]

The Therapeutic Goods Administration (TGA) is seeking expressions of interest from experts in relevant clinical or scientific fields who want to contribute to the regulation of therapeutic goods in Australia. [ + ]